These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17512239)

  • 1. Chagas cardiomyopathy (Trypanosoma cruzi): does prolactin play a role?
    Pearson RD
    Cytokine Growth Factor Rev; 2007; 18(3-4):209. PubMed ID: 17512239
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi.
    Savino W; Villa-Verde DM; Mendes-da-Cruz DA; Silva-Monteiro E; Perez AR; Aoki Mdel P; Bottasso O; Guiñazú N; Silva-Barbosa SD; Gea S
    Cytokine Growth Factor Rev; 2007; 18(1-2):107-24. PubMed ID: 17339126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One fate of bloodstream trypomastigote forms of Trypanosoma cruzi after immune clearance: an ultrastructural study.
    Umekita LF; Carneiro SM; Sesso A; Mota I
    J Parasitol; 1999 Oct; 85(5):867-72. PubMed ID: 10577722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effect of non-immunologic granulomatous inflammation in Trypanosoma cruzi infection of mice.
    De Mesquita RP
    Rev Bras Biol; 1979 Mar; 39(1):99-102. PubMed ID: 111311
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of growth hormone and prolactin secretion in Trypanosoma cruzi-infected mammosomatotrophic cells.
    Corrêa-de-Santana E; Paez-Pereda M; Theodoropoulou M; Renner U; Stalla J; Stalla GK; Savino W
    Neuroimmunomodulation; 2009; 16(3):208-12. PubMed ID: 19246944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of aberrant T-cell responses in Chagas disease.
    DosReis GA; Freire-de-Lima CG; Nunes MP; Lopes MF
    Trends Parasitol; 2005 May; 21(5):237-43. PubMed ID: 15837613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trypanosoma cruzi high parasitemia in patient with systemic lupus erythematosus].
    dos Santos-Neto LL; Polcheira MF; Castro C; Lima RA; Simaan CK; Corrêa-Lima FA
    Rev Soc Bras Med Trop; 2003; 36(5):613-5. PubMed ID: 14576877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal IFN-gamma-dependent immunoproteasome modulation by Trypanosoma cruzi-infected macrophages.
    Bergeron M; Blanchette J; Rouleau P; Olivier M
    Parasite Immunol; 2008 May; 30(5):280-92. PubMed ID: 18312504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting the oxidative assault: the Trypanosoma cruzi journey to infection.
    Piacenza L; Alvarez MN; Peluffo G; Radi R
    Curr Opin Microbiol; 2009 Aug; 12(4):415-21. PubMed ID: 19616990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Chagas disease: phagocytosis of apoptotic lymphocytes deactivates macrophages and fuels parasite growth.
    Lopes MF; DosReis GA
    Apoptosis; 2000 Jun; 5(3):221-4. PubMed ID: 11225843
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pregnancy and Trypanosoma cruzi parasitism].
    Storni P; Bolsi FL
    Medicina (B Aires); 1979; 39(2):193-7. PubMed ID: 116106
    [No Abstract]   [Full Text] [Related]  

  • 12. Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi.
    Kierszenbaum F; Knecht E; Budzko DB; Pizzimenti MC
    J Immunol; 1974 May; 112(5):1839-44. PubMed ID: 4361979
    [No Abstract]   [Full Text] [Related]  

  • 13. Sabotage and exploitation in macrophages parasitized by intracellular protozoans.
    Denkers EY; Butcher BA
    Trends Parasitol; 2005 Jan; 21(1):35-41. PubMed ID: 15639739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi: orchiectomy and dehydroepiandrosterone therapy in infected rats.
    Filipin Mdel V; Brazão V; Caetano LC; Santello FH; Toldo MP; Caetano LN; do Prado JC
    Exp Parasitol; 2008 Nov; 120(3):249-54. PubMed ID: 18700143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi: the effects of zinc supplementation during experimental infection.
    Brazão V; Del Vecchio Filipin M; Caetano LC; Toldo MP; Caetano LN; do Prado JC
    Exp Parasitol; 2008 Apr; 118(4):549-54. PubMed ID: 18177642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune system recognition of Trypanosoma cruzi.
    Tarleton RL
    Curr Opin Immunol; 2007 Aug; 19(4):430-4. PubMed ID: 17651955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi.
    Santello FH; Frare EO; dos Santos CD; Caetano LC; Alonso Toldo MP; do Prado JC
    J Pineal Res; 2008 Oct; 45(3):291-6. PubMed ID: 18373553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection.
    Melo RC
    J Cell Mol Med; 2009 Feb; 13(2):279-94. PubMed ID: 18624767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclooxygenase inhibitors on parasite burden, anemia and oxidative stress in murine Trypanosoma cruzi infection.
    Hideko Tatakihara VL; Cecchini R; Borges CL; Malvezi AD; Graça-de Souza VK; Yamada-Ogatta SF; Rizzo LV; Pinge-Filho P
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):47-58. PubMed ID: 18031539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological status of mothers infected with Trypanosoma cruzi].
    Alonso-Vega C; Hermann E; Truyens C; Rodriguez P; Torrico MC; Torrico F; Carlier Y
    Rev Soc Bras Med Trop; 2005; 38 Suppl 2():101-4. PubMed ID: 16482826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.